The United Kingdom has formally left the European Union on 31 January 2020 and has become a third country to the EU. On 1 February 2020 a transition period has started which will end on 31 December 2020. During the...
As announced previously, Marketing Authorisation Holders (MAH), that still have relevant entities located in the UK, are again reminded to make the necessary changes until 31 December 2020 to ensure that their authorised...
The State Agency of Medicines (hereinafter – Agency) has published its Annual Report of the year 2019 which summarizes information regarding the operation of the Agency during the previous year. Some of the numbers that...
On 17 March 2020, a nationwide campaign was launched in Latvia in order to inform patients about the new procedure of prescribing reimbursed medicines that comes into effect on 1 April. It provides that doctors medicines...
The most widely used in all three Baltic countries is the group of cardiovascular drugs consumption of which exceeds more than threefold the consumption of second most widely used ATC* groups in each country – shows the...
We invite our clients and collaboration partners to participate in the survey on collaboration with the State Agency of Medicines (hereinafter – Agency).
Use of medicinal product permitted, if the doctor and patient take full responsibility. On 30 May 2019, the State Agency of Medicines (Agency) suspended marketing authorisation of the medicinal product “Rigvir solution...
Please be informed that from 17 June 2019 the reception hours of the State Agency of Medicines (address: Jersikas iela 15, Riga) will be 9.00 – 11.00 AM. Consultations with the Agency experts: please request the...
